Cargando…

Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats

INTRODUCTION: Valproic acid is a medication most commonly used in the treatment of emotional and neurological depression, psychological imbalances, epilepsy, and bipolar disorder. Dark honey, like thyme honey, contains more antioxidant compounds than other samples. The purpose of this study was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Omidipour, Rezvan, Zarei, Leila, Boroujeni, Mandana Beigi, Rajabzadeh, Asghar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920727/
https://www.ncbi.nlm.nih.gov/pubmed/33688502
http://dx.doi.org/10.1155/2021/8839898
_version_ 1783658337981693952
author Omidipour, Rezvan
Zarei, Leila
Boroujeni, Mandana Beigi
Rajabzadeh, Asghar
author_facet Omidipour, Rezvan
Zarei, Leila
Boroujeni, Mandana Beigi
Rajabzadeh, Asghar
author_sort Omidipour, Rezvan
collection PubMed
description INTRODUCTION: Valproic acid is a medication most commonly used in the treatment of emotional and neurological depression, psychological imbalances, epilepsy, and bipolar disorder. Dark honey, like thyme honey, contains more antioxidant compounds than other samples. The purpose of this study was to evaluate the effect of thyme honey on the potential hepatic effects of valproic acid. METHODS: In this study, 48 male rats were randomly divided into 8 groups (n = 6): G1 (control): healthy rats (normal saline 0.9%), G2: thyme honey (1 g/kg), G3: thyme honey (2 g/kg dose), G4: thyme honey (3 g/kg dose), G5: VPA (500 mg/kg), G6: VPA (500 mg/kg) and thyme honey (1 g/kg), G7: VPA (500 mg/kg) and thyme honey (2 g/kg dose), and G8: VPA (500 mg/kg) and thyme honey (3 g/kg dose). Groups G1 to G5 received the drug for 28 days. On day 14, administration of thyme honey for G6 to G8 groups was carried out using gavage until day 28. VPA was administered one hour after honey. To carry out the biochemical evaluation, blood samples were collected from all the groups and their serums were used for MDA, TAC, and liver enzymes (AST, ALT, and GGT). Tissue samples of each rat were also removed for histological studies with hematoxylin-eosin and Masson's trichrome staining. RESULTS: The use of thyme honey significantly improved the histopathological parameters of the liver tissue, including hypertrophic degeneration and nucleus alteration, expansion of sinusoids, fibrosis and hepatic necrosis, and inflammation as well as hypertrophy of Kupffer cells. In the groups receiving VPA, the rate of lipid peroxidation increased, which indicates the destruction of the liver cell membrane due to drug consumption. TAC levels also increased following increase in thyme honey dosage (p ≤ 0.05). The results of liver enzyme analysis showed a decrease in AST and ALT levels in the G6 group and a decrease in GGT level in the G8 group (p ≤ 0.05). CONCLUSION: Based on the results of this study, it seems that high percentage of antioxidants in thyme honey enabled it to improve hepatic complications and reduce the rate of hepatocellular destruction.
format Online
Article
Text
id pubmed-7920727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79207272021-03-08 Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats Omidipour, Rezvan Zarei, Leila Boroujeni, Mandana Beigi Rajabzadeh, Asghar Biomed Res Int Research Article INTRODUCTION: Valproic acid is a medication most commonly used in the treatment of emotional and neurological depression, psychological imbalances, epilepsy, and bipolar disorder. Dark honey, like thyme honey, contains more antioxidant compounds than other samples. The purpose of this study was to evaluate the effect of thyme honey on the potential hepatic effects of valproic acid. METHODS: In this study, 48 male rats were randomly divided into 8 groups (n = 6): G1 (control): healthy rats (normal saline 0.9%), G2: thyme honey (1 g/kg), G3: thyme honey (2 g/kg dose), G4: thyme honey (3 g/kg dose), G5: VPA (500 mg/kg), G6: VPA (500 mg/kg) and thyme honey (1 g/kg), G7: VPA (500 mg/kg) and thyme honey (2 g/kg dose), and G8: VPA (500 mg/kg) and thyme honey (3 g/kg dose). Groups G1 to G5 received the drug for 28 days. On day 14, administration of thyme honey for G6 to G8 groups was carried out using gavage until day 28. VPA was administered one hour after honey. To carry out the biochemical evaluation, blood samples were collected from all the groups and their serums were used for MDA, TAC, and liver enzymes (AST, ALT, and GGT). Tissue samples of each rat were also removed for histological studies with hematoxylin-eosin and Masson's trichrome staining. RESULTS: The use of thyme honey significantly improved the histopathological parameters of the liver tissue, including hypertrophic degeneration and nucleus alteration, expansion of sinusoids, fibrosis and hepatic necrosis, and inflammation as well as hypertrophy of Kupffer cells. In the groups receiving VPA, the rate of lipid peroxidation increased, which indicates the destruction of the liver cell membrane due to drug consumption. TAC levels also increased following increase in thyme honey dosage (p ≤ 0.05). The results of liver enzyme analysis showed a decrease in AST and ALT levels in the G6 group and a decrease in GGT level in the G8 group (p ≤ 0.05). CONCLUSION: Based on the results of this study, it seems that high percentage of antioxidants in thyme honey enabled it to improve hepatic complications and reduce the rate of hepatocellular destruction. Hindawi 2021-02-20 /pmc/articles/PMC7920727/ /pubmed/33688502 http://dx.doi.org/10.1155/2021/8839898 Text en Copyright © 2021 Rezvan Omidipour et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Omidipour, Rezvan
Zarei, Leila
Boroujeni, Mandana Beigi
Rajabzadeh, Asghar
Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats
title Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats
title_full Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats
title_fullStr Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats
title_full_unstemmed Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats
title_short Protective Effect of Thyme Honey against Valproic Acid Hepatotoxicity in Wistar Rats
title_sort protective effect of thyme honey against valproic acid hepatotoxicity in wistar rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920727/
https://www.ncbi.nlm.nih.gov/pubmed/33688502
http://dx.doi.org/10.1155/2021/8839898
work_keys_str_mv AT omidipourrezvan protectiveeffectofthymehoneyagainstvalproicacidhepatotoxicityinwistarrats
AT zareileila protectiveeffectofthymehoneyagainstvalproicacidhepatotoxicityinwistarrats
AT boroujenimandanabeigi protectiveeffectofthymehoneyagainstvalproicacidhepatotoxicityinwistarrats
AT rajabzadehasghar protectiveeffectofthymehoneyagainstvalproicacidhepatotoxicityinwistarrats